While standard treatment for PMR often involves medications like steroids and methotrexate, these treatments will not be the ...

Both polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) present with a broad spectrum of clinical manifestations and almost exclusively occur in the population aged over 50 years. After ...

Don't miss the big stories. Like us on Facebook. Q: Please inform your readers about polymyalgia rheumatica. I thought I was experiencing arthritis, until my doctor informed me otherwise. A: ...

Polymyalgia rheumatica according to the Mayo Clinic is an inflammatory disorder that causes muscle pain and stiffness especially in the shoulders. Signs and symptoms of polymyalgia rheumatica usually ...

DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- Horizon Pharma, Inc., (NASDAQ: HZNP) announced today that the U.S. Food and Drug Administration (FDA) has approved RAYOS ® (prednisone) delayed-release ...

Basel, October 22, 2025 – Novartis today announced that Cosentyx® (secukinumab) met the primary endpoint and all secondary endpoints in the Phase III REPLENISH trial 1. Cosentyx demonstrated ...

An obese 30-year-old African-American woman presents at a rheumatology clinic with muscle pain and tenderness to touch throughout her body. The patient, a mechanical engineer, has been referred by her ...

Findings showed secukinumab demonstrated statistically significant and clinically meaningful sustained remission at week 52 vs placebo. Topline data were announced from a phase 3 trial evaluating ...

RAYOS approved for key rheumatology indications such as Rheumatoid Arthritis, Polymyalgia Rheumatica, Psoriatic Arthritis and Ankylosing Spondylitis. DEERFIELD, Ill., July 26, 2012 /PRNewswire/ -- ...